Scientific Advisory Board
Dr. Marek Dobke is a professor of surgery, mentor, researcher, international author, editor and speaker. +/-
Since 2000, Dr. Dobke has been the Chief of the Division of Plastic Surgery at the University of California San Diego, training residents and inspiring medical students to become plastic surgeons. Currently, his research interests include the physiology and pathology of healing processes, scientific foundations and evidence-based aesthetic surgery, research in biomaterials, and recently applications of stem-cell based technologies for plastic surgery. He also advocates for the use of telemedicine to reach out to patients in remote locations who need access to plastic surgery specialists.
Dr. Dobke is an active member of several plastic surgery associations (AAPS, ACAPS, ABPS, ABA, ASPS, ASBS, CSPS, ISBI, ISAPS, SDPSS) and is currently on the Editorial Boards for the Journal of Aesthetic and Reconstructive Surgery, as well as international journals Oncosurgery and Journal of the Head and Neck (Russian/English).
Born in Poland he graduated from the Medical Academy in Gdansk in 1974. He is Board Certified in plastic surgery in both the United States and Poland. He has developed a large practice in cosmetic and reconstructive surgery, with a special interest and clinical expertise in aesthetic and reconstructive surgery. His philosophy is that “Academic plastic surgery brings you state-of-the-art services enhanced by the newest technologies and exposure to therapies which are still subject of research and trials.
Dr. King Jordan is an Associate Professor in the School of Biology and Director of the Bioinformatics Graduate Program at the Georgia Institute of Technology. +/-
Dr. Jordan combines an educational background in Biology and Genetics with 20 years of experience in Bioinformatics. He received a BS in Biology from the University of Colorado (1992) and a PhD in Genetics from the University of Georgia (1998). Before coming to Georgia Tech in 2006, Dr. Jordan trained at the National Center for Biotechnology Information at the National Institutes of Health, the world’s leading Bioinformatics institute. Members of Dr. Jordan’s laboratory conduct research in bioinformatics and genomics with an emphasis on the analysis of large data sets towards the understanding of the molecular and genetic determinants of human health.
His research efforts involve both the development and application of computational tools specifically tailored for genomic sequence analysis and various ‘omics’ functional analyses.Dr. Jordan’s research has resulted in more than 100 publications in journals such as Nature, Proceedings of the National Academy of Sciences, Nucleic Acids Research and Bioinformatics, and he was been awarded research grants from the National Institutes of Health, the Centers for Disease Control, the Georgia Research Alliance and the Alfred P. Sloan Foundation.
Dr. Jordan is also involved in the development of Bioinformatics and Genomics capacity in Latin America. He was named a Fulbright fellow to Colombia in 2012, he is the Co-Founder and Director of the PanAmerican Bioinformatics Institute, and he serves as an external scientific advisor to BIOS – the Colombian National Center of Bioinformatics.
In addition to his academic work, Dr. Jordan consults with industry partners to provide custom solutions to their bioinformatics challenges via his company Genomic Informatics Consulting.
Dr. Mary Lopez, PhD
COO and VP of Proteomic Discovery of
Dr. Lopez has over 25 years of experience in the fields of Proteomics and Mass Spectrometry and joined Nuclea Biotechnologies in 2015. +/-
She received her PhD from the University of Massachusetts Amherst and did her postdoctoral work at MIT where she received an NIH fellowship. Dr Lopez has held leadership positions in several Health related and Biotechnology companies including Millipore Corp., Perkin Elmer and most recently, Thermo Fisher Scientific. She has authored over 70 peer reviewed publications in her field, has been awarded several patents and serves on the Scientific Advisory Board of the Clinical Proteomics Research Center at Massachusetts General Hospital. Dr Lopez is also on the Board of the US Human Proteome Organization (HUPO) and is an associate editor of Clinical Proteomics.
Michael Rosenblum, MD, PhD
Assistant Clinical Professor, Department
of Dermatology, UCSF
Dr. Rosenblum is a formally trained basic immunologist and a board-certified dermatologist. He is currently an Assistant Professor in the UCSF Department of Dermatology. +/-
He dedicates 85% of his time to basic research and the remaining time taking care of patients with specific inflammatory and autoimmune skin diseases. The central focus of his laboratory is to understand the fundamental mechanisms of how immune responses are regulated in peripheral tissues, and how this knowledge can be exploited for therapeutic benefit.